Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Carcinoma in Situ and AKT1[original query] |
---|
PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression. Breast cancer research and treatment 2011 Sep 129 (2): 635-43. Kalinsky Kevin, Heguy Adriana, Bhanot Umeshkumar K, Patil Sujata, Moynahan Mary Ell |
Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Jul 25 (7): 930-7. Troxell Megan L, Brunner Alayne L, Neff Tanaya, Warrick Andrea, Beadling Carol, Montgomery Kelli, Zhu Shirley, Corless Christopher L, West Robert |
Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 May 27 (5): 740-50. Ang Daphne C, Warrick Andrea L, Shilling Amy, Beadling Carol, Corless Christopher L, Troxell Megan |
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer. Oncotarget 2015 Apr 6 (10): 7597-607. Kim Shinn Young, Jung Seung-Hyun, Kim Min Sung, Baek In-Pyo, Lee Sung Hak, Kim Tae-Min, Chung Yeun-Jun, Lee Sug Hyu |
- Page last reviewed:Feb 1, 2024
- Content source: